Chartwell Investment Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Chartwell Investment Partners’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$551K	Hold	13,759	–	–	0.02%	393
2024 Q2	$656K	Buy	13,759 +2,003	+17%	+$82.2K	0.02%	380
2024 Q1	$510K	Sell	11,756 -1,226	-9%	-$58.4K	0.02%	397
2023 Q4	$657K	Buy	+12,982	New	+$622K	0.02%	391
2016 Q2	–	Sell	-327,220	Closed	-$13.3M	–	415
2016 Q1	$13.3M	Buy	327,220 +29,481	+10%	+$1.2M	0.25%	112
2015 Q4	$18.4M	Buy	297,739 +53,552	+22%	+$2.89M	0.38%	71
2015 Q3	$9.87M	Buy	244,187 +157,187	+181%	+$8.14M	0.21%	158
2015 Q2	$5.01M	Sell	87,000 -125,040	-59%	-$7.95M	0.1%	224
2015 Q1	$13.5M	Buy	212,040 +33,600	+19%	+$2.28M	0.26%	150
2014 Q4	$11M	Buy	+178,440	New	+$8.81M	0.23%	183

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Chartwell Investment Partners's IONS Position: Q3 2024 in Review

Chartwell Investment Partners held its Ionis Pharmaceuticals (IONS) position steady in Q3 2024 at 13,759 shares worth $551K. The position accounts for 0.02% of the portfolio, ranked #393.

Chartwell Investment Partners first reported a position in IONS in Q4 2014 and has held it in 10 quarters since. The position peaked at $18.4M in Q4 2015. 354 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

Chartwell Investment Partners held 13,759 shares of Ionis Pharmaceuticals worth $551K as of Q3 2024.
Chartwell Investment Partners left its Ionis Pharmaceuticals share count unchanged in Q3 2024.
Ionis Pharmaceuticals made up 0.02% of Chartwell Investment Partners's portfolio in Q3 2024, its #393 holding.
Chartwell Investment Partners first reported a position in Ionis Pharmaceuticals in Q4 2014 and has held it in 10 quarters since.
Chartwell Investment Partners's Ionis Pharmaceuticals position peaked at $18.4M in Q4 2015.
354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.